VitalConnect offers wearable and wireless devices, powered by biosensor technology to remote-monitor hospital patients and stay-at-home seniors. The platform focuses on the cardiac monitoring space through its VitalPatch RTM device. Its flagship product (VitalPatch) is a disposable biosensor that is worn on a patient’s chest, and as of January 2022, the company has deployed more than 200,000 patches globally, including assisted living facilities such as Brigham and Women’s, Hackensack Medical Center, Northwell Health, and John Radcliffe Hospital-Oxford University. It also offers a COVID management solution called “VistaSolution,” which consists of VitalPatch, VistaTablet/phone (mobile device to transfer information from patch to cloud) and Vista Center (a centralized monitoring system), to monitor COVID-19 patients.
Key customers and partnerships
As of July 2023, VitalConnect has deployed its solution, both within the US and internationally, in various healthcare settings such as Brigham and Women’s Hospital, Hackensack Medical Center, Northwell Health, and John Radcliffe Hospital-Oxford University.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.